PL324200A1 - Compunds exhibiting growth hormone liberating properties - Google Patents
Compunds exhibiting growth hormone liberating propertiesInfo
- Publication number
- PL324200A1 PL324200A1 PL96324200A PL32420096A PL324200A1 PL 324200 A1 PL324200 A1 PL 324200A1 PL 96324200 A PL96324200 A PL 96324200A PL 32420096 A PL32420096 A PL 32420096A PL 324200 A1 PL324200 A1 PL 324200A1
- Authority
- PL
- Poland
- Prior art keywords
- compunds
- liberating
- properties
- growth hormone
- exhibiting growth
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 230000001747 exhibiting effect Effects 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK71995 | 1995-06-22 | ||
| DK137195 | 1995-12-04 | ||
| PCT/DK1996/000266 WO1997000894A1 (en) | 1995-06-22 | 1996-06-19 | Compounds with growth hormone releasing properties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL324200A1 true PL324200A1 (en) | 1998-05-11 |
| PL186520B1 PL186520B1 (en) | 2004-01-30 |
Family
ID=26064522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL96324200A PL186520B1 (en) | 1995-06-22 | 1996-06-19 | Compunds exhibiting growth hormone liberating properties |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0833845A1 (en) |
| KR (1) | KR19990028303A (en) |
| AU (1) | AU711104B2 (en) |
| BR (1) | BR9608909A (en) |
| CA (1) | CA2224434A1 (en) |
| CZ (1) | CZ287948B6 (en) |
| HU (1) | HUP9802821A3 (en) |
| IL (1) | IL122371A0 (en) |
| NO (1) | NO975992L (en) |
| PL (1) | PL186520B1 (en) |
| TW (1) | TW458958B (en) |
| WO (1) | WO1997000894A1 (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008492A1 (en) * | 1996-08-29 | 1998-03-05 | Novo Nordisk A/S | Transdermal delivery of peptides |
| JP4116097B2 (en) | 1997-06-20 | 2008-07-09 | ノボ ノルディスク アクティーゼルスカブ | Compounds with growth hormone releasing properties |
| US6127341A (en) * | 1997-06-20 | 2000-10-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| CA2301566A1 (en) | 1997-08-22 | 1999-03-04 | Kaken Pharmaceutical Co., Ltd. | N-acylated lipophilic amino acid derivatives |
| EP1047709B1 (en) | 1998-01-16 | 2004-11-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| EA003860B1 (en) * | 1998-05-12 | 2003-10-30 | Варнер-Ламберт Компани | Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| US6919315B1 (en) | 1998-06-30 | 2005-07-19 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| AU771644B2 (en) * | 1998-06-30 | 2004-04-01 | Helsinn Healthcare Sa | Compounds with growth hormone releasing properties |
| WO2000009537A2 (en) | 1998-08-14 | 2000-02-24 | Administrators Of The Tulane Educational Fund | Compounds having growth hormone releasing activity |
| WO2000048623A1 (en) | 1999-02-18 | 2000-08-24 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
| DE60140285D1 (en) | 2000-05-31 | 2009-12-10 | Pfizer Prod Inc | Use of growth hormone secretagogues to promote the mobility of the digestive tract |
| EP1343751A2 (en) | 2000-12-20 | 2003-09-17 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| HUP0303540A2 (en) | 2000-12-20 | 2004-01-28 | Bristol-Myers Squibb Pharma Co. | Diamines as modulators of chemokine receptor activity, pharmaceutical compositions containing them and their use |
| TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| CU23558A1 (en) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE |
| EA200901077A1 (en) | 2007-02-09 | 2010-04-30 | Транзим Фарма, Инк. | MACRO CYCLIC MODULATORS OF THE GREEL RECEPTOR AND THEIR APPLICATION |
| WO2009079797A1 (en) | 2007-12-26 | 2009-07-02 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
| WO2010006438A1 (en) | 2008-07-17 | 2010-01-21 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| US8987272B2 (en) | 2010-04-01 | 2015-03-24 | Critical Outcome Technologies Inc. | Compounds and method for treatment of HIV |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| SK281963B6 (en) * | 1993-12-23 | 2001-09-11 | Novo Nordisk A/S | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use |
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
-
1996
- 1996-06-19 PL PL96324200A patent/PL186520B1/en unknown
- 1996-06-19 KR KR1019970709617A patent/KR19990028303A/en not_active Application Discontinuation
- 1996-06-19 HU HU9802821A patent/HUP9802821A3/en unknown
- 1996-06-19 WO PCT/DK1996/000266 patent/WO1997000894A1/en not_active Application Discontinuation
- 1996-06-19 AU AU61882/96A patent/AU711104B2/en not_active Ceased
- 1996-06-19 BR BR9608909A patent/BR9608909A/en not_active Application Discontinuation
- 1996-06-19 CA CA002224434A patent/CA2224434A1/en not_active Abandoned
- 1996-06-19 IL IL12237196A patent/IL122371A0/en not_active IP Right Cessation
- 1996-06-19 EP EP96920742A patent/EP0833845A1/en not_active Withdrawn
- 1996-06-19 CZ CZ19974081A patent/CZ287948B6/en not_active IP Right Cessation
- 1996-06-28 TW TW085107813A patent/TW458958B/en not_active IP Right Cessation
-
1997
- 1997-12-19 NO NO975992A patent/NO975992L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990028303A (en) | 1999-04-15 |
| PL186520B1 (en) | 2004-01-30 |
| IL122371A0 (en) | 1998-06-15 |
| JPH11507928A (en) | 1999-07-13 |
| JP4173541B2 (en) | 2008-10-29 |
| BR9608909A (en) | 1999-03-02 |
| AU6188296A (en) | 1997-01-22 |
| NO975992L (en) | 1998-02-20 |
| AU711104B2 (en) | 1999-10-07 |
| TW458958B (en) | 2001-10-11 |
| MX9710377A (en) | 1998-03-29 |
| CA2224434A1 (en) | 1997-01-09 |
| HUP9802821A3 (en) | 2000-03-28 |
| NO975992D0 (en) | 1997-12-19 |
| HUP9802821A2 (en) | 1999-03-29 |
| CZ287948B6 (en) | 2001-03-14 |
| CZ408197A3 (en) | 1998-05-13 |
| EP0833845A1 (en) | 1998-04-08 |
| WO1997000894A1 (en) | 1997-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL324200A1 (en) | Compunds exhibiting growth hormone liberating properties | |
| HUP9802580A3 (en) | Compounds with growth hormone releasing properties | |
| AU6772996A (en) | 2-acylaminopropanamides as growth hormone secretagogues | |
| EP0858351A4 (en) | Anti-coring needle | |
| HUP9900301A3 (en) | Hormone patch | |
| EP0871705A4 (en) | Human ccn-like growth factor | |
| EP0741578A4 (en) | Human growth hormone | |
| AU6724496A (en) | 2-acylaminopropanamines as growth hormone secretagogues | |
| AU1048797A (en) | Float garment | |
| ZA961007B (en) | Compounds with growth hormone releasing properties | |
| EP0833904A4 (en) | Fibroblast growth factor-14 | |
| ZA961008B (en) | Compounds with growth hormone releasing properties | |
| AU4453396A (en) | Growth factor analogs | |
| PL325170A1 (en) | Bipolar forms of throwaflocacin | |
| EP0796095A4 (en) | Methods of inhibiting growth hormone effects | |
| GB2307644B (en) | Resectoscope | |
| GB9424232D0 (en) | Growth factor expression | |
| GB9516247D0 (en) | Socks | |
| EP0891372A4 (en) | Growth factor htter36 | |
| ZA965279B (en) | Compounds with growth hormone releasing properties | |
| ZA9610775B (en) | Compounds with growth hormone releasing properties | |
| ZA96544B (en) | Compounds with growth hormone releasing properties | |
| AU124629S (en) | Small flower pot | |
| ZA967973B (en) | Human growth hormone variants | |
| AU125290S (en) | Sinker |